GL1X · GenesisL1 explorer

MolNFT v1 · #42229 · protein

Binding of the anticancer drug ZD1694 to E. COLI thymidylate synthase: assessing specificity and affinity

2KCE: “Binding of the anticancer drug ZD1694 to E. COLI thymidylate synthase: assessing specificity and affinity”. X-ray diffraction, 2 ligands (UMP, D16), 6 pockets (best druggability 0.76). MolNFT v1 #42229 on GenesisL1: 3D structure…

PDB
2KCE
Type
protein
Length
528 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thymidylate synthase
EC
2.1.1.45
UniProt
P0A884
Ligands
UMP, D16
Pockets
6 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BThymidylate synthase (EC 2.1.1.45)protein26437% helix, 26% strandP0A884

Ligands and binding sites

  • UMP · 2'-deoxyuridine 5'-monophosphate · ligand · 2 copies · chains A, B
  • D16 · Tomudex · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14470.760.8544UMP, D16
24200.760.8548UMP, D16
31080.400.7619empty
4990.400.7719empty
5860.390.7718empty

Interfaces

1 interface between chains.

  • A–B · 2363 Ų buried · 36 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 2KCE · Binding of the anticancer drug ZD1694 to E. COLI thymidylate synthase: assessing… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0A884 · AlphaFold monomer V2.0 prediction for thymidylate synthase (P0A884) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.